A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia: results of the LI-1 trial

Mike Dennis*, Alan Burnett, Robert Hills, Ian Thomas, Cono Ariti, Marianne T Severinsen, Claire Hemmaway, Paul Greaves, Richard E Clark, Mhairi Copland, Nigel Russell, National Cancer Research Institute (NCRI) acute myeloid leukaemia (AML) Working Group

*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia: results of the LI-1 trial'. Together they form a unique fingerprint.

Medicine and Dentistry